croup
CROUP
Croup is a viral infection that causes erythema and edema of the tracheal walls and narrowing of the subglottic region. It is often characterized by an acute, rapidly progressing respiratory disease.
It is a medical emergency in children and requiring immediate treatment.
Most common causes are parainfluenza virus 1&2 and respiratory syncytial virus.
Occurrence of symptoms is usually at night and with abrupt onset and improve during daytime.

Croup Signs and Symptoms

Introduction

Croup is often characterized by an acute, rapidly progressing respiratory disease
  • Also referred to as laryngotracheitis, laryngotracheobronchitis, & laryngotracheobronchopneumonitis 
  • Common cause of upper respiratory tract obstruction in children
  • Rarely occurs in adults
  • Often self-limiting but may possibly cause severe respiratory obstruction
  • Develops concurrent w/ coryzal disease

Etiology

  • Most common causes of croup:
    • Parainfluenza virus 1-3 (type 1 being most common) 
    • Respiratory syncytial virus

Signs and Symptoms

  •  Occurrence of symptoms is usually at night & w/ abrupt onset, & improve during daytime
    • Barking cough
    • Dyspnea, w/ possible rapid progression to airway obstruction
    • Hoarse voice
    • Inspiratory stridor may be severe & may herald complete airway obstruction
    • Fever may or may not occur
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 3 days ago
Gefapixant, a first-in-class non-narcotic, oral P2X3 receptor antagonist, significantly reduces cough frequency in patients with refractory or unexplained chronic cough, according to two COUGH* studies presented at ERS 2020.
Roshini Claire Anthony, 18 Jul 2020

The concurrent occurrence of diabesity and COVID-19 may lead to more severe disease due to the latter, according to a presentation at the Opening Session of ENDO Online.

Pearl Toh, 18 Jan 2020
Almost three-quarters of adverse events (AEs) related to medication errors in over-the-counter (OTC) cough and cold medications (CCMs) for paediatrics required evaluation by healthcare facility and majority of the cases were due to dosing errors, a surveillance study has found, highlighting the need for interventions to mitigate medication errors.
Pearl Toh, 5 days ago
Mepolizumab, a first-in-class anti-IL-5* antibody, effectively prevents asthma exacerbations in patients with severe eosinophilic asthma (SEA), according to a presentation at the ERS 2020 Congress.